These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 17175564

  • 1. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS.
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [Abstract] [Full Text] [Related]

  • 2. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 3. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM, Gainsborough N, Rajkumar C.
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract] [Full Text] [Related]

  • 4. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG, Gulløv AL, Petersen P.
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [Abstract] [Full Text] [Related]

  • 5. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.
    Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237
    [Abstract] [Full Text] [Related]

  • 6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 11; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 7. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May 11; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 8. Antithrombotic therapy in atrial fibrillation.
    Turpie AG, Connolly SJ.
    Can Fam Physician; 1996 Jul 11; 42():1341-5. PubMed ID: 8754703
    [Abstract] [Full Text] [Related]

  • 9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 11; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 10. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY, Zhang HP, Sun YH, Jiang LQ, Antithrombotic Therapy in Atrial Fibrillation Study Group.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr 11; 34(4):295-8. PubMed ID: 16776915
    [Abstract] [Full Text] [Related]

  • 11. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG, Feddersen C, Gulløv AL, Petersen P.
    Thromb Haemost; 1997 May 11; 77(5):845-8. PubMed ID: 9184390
    [Abstract] [Full Text] [Related]

  • 12. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M, Gross B.
    Int J Cardiol; 2004 Jul 11; 96(1):89-95. PubMed ID: 15203266
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
    Arch Intern Med; 1997 Jun 09; 157(11):1237-40. PubMed ID: 9183235
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K.
    Age Ageing; 2005 Jan 09; 34(1):35-40. PubMed ID: 15591481
    [Abstract] [Full Text] [Related]

  • 15. Atrial fibrillation and anticoagulation.
    Garnier LF, Rouesnel P, Espitalier F.
    Arch Mal Coeur Vaiss; 2004 Oct 09; 97(10):1001-5. PubMed ID: 16008178
    [Abstract] [Full Text] [Related]

  • 16. Atrial fibrillation, thromboembolism and antithrombotic therapy.
    Li-Saw-Hee FL, Lip GY.
    Int J Clin Pract; 1999 Mar 09; 53(2):110-7. PubMed ID: 10344046
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombotic treatment in atrial fibrillation.
    Lip GY, Boos CJ.
    Postgrad Med J; 2008 May 09; 84(991):252-8. PubMed ID: 18508982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis.
    Andersen LV, Vestergaard P, Deichgraeber P, Lindholt JS, Mortensen LS, Frost L.
    Heart; 2008 Dec 09; 94(12):1607-13. PubMed ID: 18208828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.